Published on in Vol 25 (2023)
Preprints (earlier versions) of this paper are
available at
https://preprints.jmir.org/preprint/43883, first published
.
1 AstraZeneca BV, The Hague, Netherlands
2 Signant Health, London, United Kingdom
3 Oxford PharmaGenesis, Oxford, United Kingdom
4 AstraZeneca, Gothenburg, Sweden
5 Nottingham Trent University, Nottingham, United Kingdom